Blood Group H Tetrasaccharide is a key glycan structure, also referred to as the type 2 H antigen. It features a branched oligosaccharide sequence: Fucα1-2Galβ1-4GlcNAcβ1-3Galβ1-, with an approximate molecular formula of C₂₄H₄₂O₂₁ for its core tetrasaccharide unit. This structure serves as the essential precursor for A and B blood group antigens, formed through the addition of α-L-fucose to the terminal galactose by specific fucosyltransferases.
Biological Sources and Occurrence
The H tetrasaccharide is prominently expressed on red blood cell surfaces in individuals with blood group O and functions as a precursor in A, B, and AB phenotypes. It is also found in bodily secretions and various tissues through its presence in N- and O-linked glycans. Notably, several strains of norovirus recognize and bind this glycan as a receptor, with crystallographic studies revealing intricate hydrogen-bond interactions in the viral P domain that specifically recognize fucose and galactose residues.
Biosynthesis and Metabolism
The biosynthesis of the blood group H tetrasaccharide involves sequential glycosyltransferase activities. Galactosyltransferase first adds Galβ1-4 to GlcNAc, followed by the action of fucosyltransferases FUT1 or FUT2, which attach Fucα1-2 to the galactose residue, generating the H epitope from lactosamine precursors. Additional modifications by A or B transferases introduce GalNAc or Gal to form the A or B antigens. Catabolic degradation is mediated by exoglycosidases within lysosomal pathways.
Research Applications
Blood group H tetrasaccharide plays a central role in multiple research areas. Structural studies of glycosyltransferases in complex with H antigen analogs provide insights into donor substrate recognition and catalytic specificity, facilitating the development of inhibitors targeting blood group–associated pathogens. The molecule is crucial for investigating norovirus binding preferences, analyzing glycan conformational dynamics through NMR, and developing glycan microarrays for antibody specificity profiling in transfusion medicine. Synthetic derivatives also support studies on Ley and A-pentasaccharide extensions, particularly in the context of cancer glycobiology.